Engineered STING-targeting immunotherapy delays B16 melanoma tumor growth and significantly improves animal survival as compared to an immunecheckpoint inhibitor

Category Primary study
JournalCancer Research
Year 2017
This article has no abstract
Epistemonikos ID: 2d01a72cdc9a6f9dd7f2fe354647038fb0329a48
First added on: Feb 08, 2025